Continuous Glucose Monitor

Signos CGM Program

Overview

Signos excels in safety (FDA clearance, established Dexcom tech safe in 100+ diabetes trials) and quality (transparent hardware/app integration), but effectiveness limited by absence of RCTs proving weight loss (only observational LST correlation PMID 39078656; ongoing NCT05121844). Matches 'continuous wear' protocol but evidence for non-diabetics weak vs diabetes (strong meta-analyses). Overall balanced for metabolic tracking, not proven weight loss tool. Value competitive at $129/mo vs $200+ p

Key strengths

Our analysis

FDA-cleared Signos CGM Program uses accurate Dexcom Stelo for real-time glucose insights aiding metabolic awareness. Safe per device standards and predicate trials, but lacks RCTs confirming weight loss (observational LST correlation only). Good for tracking, monitor ongoing trials.

Frequently asked questions

Is Signos CGM Program worth buying?
Signos CGM Program has a Verify Influencers trust score of 65/100 based on ingredient quality, clinical evidence, and third-party testing.
What is the trust score for Signos CGM Program?
Signos CGM Program scored 65 out of 100 in our science-backed analysis, which evaluates ingredient dosages against clinical literature and manufacturing transparency.

Browse all scored products · How products are scored